Weber Barbara 4
4 · Revolution Medicines, Inc. · Filed Sep 6, 2023
Insider Transaction Report
Form 4
Weber Barbara
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-09-01−11,146→ 1,851 totalExercise: $4.73From: 2022-02-09Exp: 2029-08-08→ Common Stock (11,146 underlying) - Exercise/Conversion
Common Stock
2023-09-01$4.73/sh+11,146$52,721→ 30,825 total - Sale
Common Stock
2023-09-01$35.07/sh−15,000$526,001→ 15,825 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-09-01−3,854→ 9,635 totalExercise: $1.12From: 2022-04-20Exp: 2028-04-19→ Common Stock (3,854 underlying) - Exercise/Conversion
Common Stock
2023-09-01$1.12/sh+3,854$4,316→ 19,679 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022.
- [F2]Includes 5,200 restricted stock units.
- [F3]The transaction was executed in multiple trades in prices ranging from $35.00 to $35.24, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.